GOP Rep. Lawler calls marijuana 'gateway drug' in opposing Trump rescheduling plan
Source: SeekingAlpha
2025-12-16 15:04:23 ET
More on Curaleaf, Trulieve Cannabis
- Trulieve's Rally Is A Chance To Exit
- Why I'm Buying Curaleaf Before The 2026 Hemp Ban Kicks In
- Curaleaf: Strong Q3 Results, But Volatility Returns To Cannabis Sector
- Trump confirms Executive Order to reclassify marijuana under consideration
- Trump could seek Executive Order to reclassify marijuana - report
Read the full article on Seeking Alpha
For further details see:
GOP Rep. Lawler calls marijuana 'gateway drug' in opposing Trump rescheduling plan
Amplify ETF Trust - Amplify Seymour Cannabis ETF
NASDAQ: CNBS
CNBS Trading
-0.26% G/L:
$23.03 Last:
5,347 Volume:
$22.20 Open:
